Obstructive Sleep Apnea

Healio has compiled the most-read news in pulmonology posted in July.

Adults with elevated plasma homocysteine concentrations had greater apnea-hypopnea index scores, signaling more severe sleep apnea, according to results published in European Archives of Oto-Rhino-Laryngology.

Around 20% of patients with obstructive sleep apnea starting positive airway pressure reported dry throat/mouth, waking too early and mask discomfort as bothersome issues of the therapy, according to research presented at SLEEP 2024.

Doctors from across the world gathered at this year’s American Thoracic Society International Conference in San Diego to present research on various respiratory diseases and conditions.

SAN DIEGO — Among adults with obstructive sleep apnea, positive airway pressure therapy reduced the risk for all-cause and cardiovascular mortality, according to a presentation at the American Thoracic Society International Conference.

Published results showed obstructive sleep apnea had a significant association with overall complications, as well as pulmonary and thromboembolic complications, among patients after total joint arthroplasty.

A positive airway pressure mask made of textile material was well received by adults with obstructive sleep apnea but did not change device usage hours, according to research presented at SLEEP 2024.

Potential risk factors for lung cancer reoccurrence within 2 years include obstructive sleep apnea-related episodic hypoxemia and hypoxic burden, according to research presented at SLEEP 2024.

ORLANDO — The GIP/GLP-1 dual agonist tirzepatide reduced symptoms of obstructive sleep apnea and improved multiple cardiometabolic markers for adults with obesity and obstructive sleep apnea, according to data from the SURMOUNT-OSA trial.

In patients with obesity and obstructive sleep apnea, those who had weight-loss surgery had approximately 40% reduced risk for major adverse CV events and death compared with those who did not, according to the results of the MOSAIC study.